Defining recovery in children

Research abstract:

Aims:  To describe how recovery from paediatric CFS/ME is defined, how many children recover and how long it takes.

Methods:  We conducted detailed literature searches of MEDLINE, EMBASE, PsycInfo and the Cochrane library, searched trial registration sites, contacted authors if results have not been published and hand searched reference lists. Three categories of search terms were used; paediatric, CFS/ME and recovery.

Inclusion criteria: Randomised controlled trials or observational studies of participants <19 years old with a diagnosis of CFS/ME, related to a Western Health Care system, some measure of recovery (partial or full) reported and the time taken to reach it.

Results: 21 papers were identified. The study populations ranged from 1 to 64 participants, their duration of illness ranged from 3 months to 7 years between studies and also showed great variety within each study. Some studies used a single measurement outcome for recovery, others measured several and some integrated multiple outcomes to formulate one value for recovery.

The recovery rate ranged from 25–100% in those accessing treatment and 4.5–100% in those without specialist care. School attendance was the most common measurement outcome (n = 11), of which 4 of these combined this with at least one other measure. 7 studies measured physical ability as an outcome, 8 used fatigue and 9 measured a global improvement that was either self-rated or qualitatively assessed by an investigator. 2 studies described recovery as no longer fulfilling the diagnostic criteria.

Conclusion: Recovery rates are relatively high in children accessing specialist treatment however, the discrepancies between the measurement outcomes, makes interpretation of recovery rates difficult.

G358 A systematic review to identify the definitions of recovery for paediatric patients with chronic fatigue syndrome (cfs) or myalgic encephalomyelitis (me), by used in studies since 1994, by Y Moore, NME Anderson, E Crawley in Arch Dis Child 2015;100:A146-A147

Posted in News | Tagged , , , , , | Comments Off on Defining recovery in children

Gwyn’s sponsored walk for ME Research UK

Ex ME Sufferer Gwyn Hopkins is to walk 150 miles to raise money for charity ME Research UK.

 

“I suffered from ME. for 5 years, at first bed bound, then in a wheelchair.  I made a complete recovery by the end of 2003.  In June 2006 I backpacked across Wales 230 miles and raised money for ME Research UK.

ME Research UK is a charity funding biomedical research into Myalgic Encephalomyelitis (also known as ME/CFS) and related illnesses. Their principal aim is to commission and fund high-quality scientific (biomedical) investigation

Over the last few years I’ve walked over 870 miles for the charity. When asked why I do it, I say because I can and it’s a joy to feel well and be out in nature again after spending years in bed. This walk is special to me because it will mean I’ll have walked over 1,000 miles for charity since my recovery.

And if I can help or inspire ME sufferers at the same time, that’s great. I think ME sufferers are the forgotten people, often living between their own four walls with very little support or understanding. I was told I had very little hope of making a complete recovery and I want others to realise they should never give up. I made it thanks to Complementary Therapies and great family support.

I’m happy to talk to sufferers and their carers if they wish to contact me.

On June 10th 2015 I will start from Cardigan, head towards Lampeter, then up to Lake Bala and across to Llangollen. I will be mostly camping on route.

To donate to the charity, visit www.justgiving.com/GwynethHopkins

Or Text GHME88 then the amount (£1, 2, 3, 4, 5, or £10) to 70070

gwyn@gwynhopkins.co.uk    www.gwynhopkins.co.uk  07950160389

 

 

 

 

Posted in News | Tagged , , | Comments Off on Gwyn’s sponsored walk for ME Research UK

IOM report comment

Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An IOM Report on Redefining an Illness, by Ellen Wright Clayton MD JD in JAMA March 17, 2015, Vol 313, No. 11

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a multisystem and often long-lasting disorder, with manifestations that can cause substantial morbidity and can severely impair patients’ health and well-being. It is estimated that between 836 000 and 2.5 million individuals are affected in the United States.1,2 Patients with ME/CFS are typically unable to perform their normal activities, and as many as one-fourth are homebound or bedridden, sometimes for extended periods.3 As a result, the personal and social effects and ramifications of this disease are enormous.

However, ME/CFS is poorly accepted and poorly understood, and the characteristics necessary to make the diagnosis are contested. Patients’ concerns are often met with dismay and skepticism, if not outright dismissal. Clinicians, in turn, are confronted by competing definitions, which were usually developed for research and are quite complex and difficult to implement in a busy clinical practice. Patients who are fortunate enough and persistent enough to receive a correct diagnosis frequently report long delays before their disorder was identified. It is almost certainly the case that the majority of affected patients are never diagnosed. This is unfortunate because effective symptom management is often available, whereas the wrong interventions can make symptoms worse.

Making the diagnosis is essential for providing appropriate care. To that end, the Department of Health and Human Services (HHS), together with the National Institutes of Health, US Social Security Administration, US Food and Drug Administration, Centers for Disease Control and Prevention, and Agency for Healthcare Research and Quality, tasked the Institute of Medicine (IOM) to develop “evidence-based clinical diagnostic criteria for ME/CFS for use by clinicians, using a consensus-building methodology,” with input from patients and clinicians; to “recommend whether new terminology for ME/CFS should be adopted”; and to create plans for disseminating these conclusions to clinicians. To meet its charge, the IOM committee heard testimony from patients, clinicians, and researchers, carefully reviewed almost one thousand public comments, and conducted a comprehensive literature review. Currently available evidence permitted the committee, in its newly released report,4 to identify symptoms and findings that collectively identify the disorder for which a new name was proposed, as discussed below. These criteria are set forth in the accompanying Box.

Frequency and severity of symptoms should be assessed. The diagnosis of systemic exertion intolerance disease (myalgic encephalomyelitis/chronic fatigue syndrome) should be questioned if patients do not have these symptoms at least half of the time with moderate, substantial, or severe intensity.

To assist with diagnosis, the committee developed an algorithm incorporating these criteria as well as an extensive list of findings on history, physical examination, and, when needed to clarify symptoms, tests that support the diagnosis. Further details, including recommended checklists, are contained in the committee’s report.4 The committee called on HHS to develop focused, evidence-based tools that will help clinicians make this diagnosis efficiently. Patients with ME/CFS, like many other patients, often have comorbid conditions that clinicians also must be prepared to identify and treat.

The committee concluded that a new name—systemic exertion intolerance disease—was warranted to capture the essence of this disorder until causation and pathophysiology are better delineated by research. Although patients differ in their triggers and manifestations, the salient feature of this disorder is that any kind of exertion—physical, cognitive, emotional—can adversely affect these patients in many aspects of their biological function and in their lives, frequently severely and often for a prolonged period. “Myalgic encephalomyelitis,” for which many people who provided input to the IOM study through testimony and public comments advocated, simply does not describe this disorder.

“Chronic fatigue syndrome” fails to depict the complexity of this disease and is also unacceptable to many patients and their advocates, who reported that this term leads clinicians and others to belittle or even dismiss their disease. The new name, which should be accompanied by a new International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) code, also distinguishes this definition from previous ones. Thus, patients who meet these new criteria should be diagnosed with systemic exertion intolerance disease even if they also meet criteria for earlier variants of ME/CFS.

Patients will not be identified and treated if clinicians do not know about the disorder and how to diagnose it. To that end, the IOM report sets forth a variety of strategies that must be pursued to facilitate dissemination of these recommendations to clinicians, patients, and K-12 education professionals, such as school nurses and psychologists. The IOM is creating educational materials for patients and clinicians.

Although the committee was able to make high-quality recommendations based on the available evidence, the need for more research is clear. Most of the research that has been conducted to date has compared small numbers of affected patients with healthy controls, not with patients with other complex fatiguing disorders. This fact, coupled with years of limited funding, means that despite the dedicated efforts of researchers in this field, many questions remain unanswered. More needs to be learned about what causes this disorder, what factors affect its course, and what therapies work for which patients. New knowledge may make it possible to identify subsets of systemic exertion intolerance disease and to provide the foundation for better diagnosis and treatment.

The IOM’s new report4 provides the foundation for greater action to diagnose and treat patients with systemic exertion intolerance disease and to learn more about the disease that affects them. This opportunity must be seized. These patients, who for too long have received inadequate attention in research and clinical settings, deserve better.

Posted in News | Tagged , , | Comments Off on IOM report comment

Effect of household tasks on people with chronic fatigue & their partners

Research abstract:

This study examined salivary cortisol levels in couples in which one member had unexplained chronic fatigue (CF). The couples completed questionnaires and seven household activities in a laboratory setting and provided salivary cortisol samples prior to and immediately after the activities, as well as again after completing additional questionnaires and debriefing.

The couples rated their interactions as similar to those at home, suggesting ecological validity, and patients with CF experienced the activities as involving more exertion than did their partners.

The multilevel model results indicated that patients with CF had overall lower cortisol levels and flatter slopes across repeated measurements than did their significant others. Patients’ and significant others’ cortisol concentrations were significantly associated with each other over time. Furthermore, significant others’ cortisol was associated with greater relationship satisfaction and greater observed rates of patients’ illness/pain behaviors per minute, but patients’ levels of cortisol were not associated with relationship variables.

This study is the first to examine cortisol in couples with CF; the results are discussed in terms of implications for future research.

Salivary cortisol responses to household tasks among couples with unexplained chronic fatigue by Karen B Schmaling, Joan M Romano, Mark P Jensen, Charles W Wilkinson, Sterling McPherson in Journal of Family Psychology, Vol 29(2), Apr 2015, 296-301

 

 

Posted in News | Tagged , , , , , | Comments Off on Effect of household tasks on people with chronic fatigue & their partners

Comparison of consensus & empirical ME/CFS definitions & criteria

Research abstract:

Background:  Since the publication of

  • the CFS case definition [Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A.
  • The chronic fatigue  syndrome: a comprehensive approach to its definition and study. Ann Intern Med. 1994;121:953-959],

there have been a number of other criteria proposed including

  • the Canadian Consensus Criteria [Carruthers BM, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, Lerner AM, Bested AC, Flor-Henry P, Joshi P, Peter Powles AC, Sherkey JA, van de Sande MI.
  • Encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatments protocols.  J Chronic Fatigue Syndr. 2003;11:7-115] and
  • Myalgic  Encephalomyelitis: International Consensus Criteria [Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, Staines D, Powels AC, Speight N, Vallings R, Bateman L, Baumgarten-Austrheim B, Bell DS, Carlo-Stella N, Chia J, Darragh A, Jo D, Lewis D, Light AR, Marshall-Gradisbik S, Mena I, Mikovits JA, Miwa K, Murovska M, Pall ML, Stevens S.
  • Myalgic encephalomyelitis: international consensus criteria. J Internal Med. 2011;270(4):327-338; Jason LA, Evans M, Brown M, Porter N, Brown A, Hunnell J, Anderson V, Lerch A.
  • Fatigue scales and chronic fatigue syndrome: issues of sensitivity and specificity. Disabil Stud Q. 2011;31:PMCID:  PMC3181109; Jason LA, Jessen T, Porter N, Boulton A, Njoku MG, Friedberg F.
  • Examining types of fatigue among individuals with ME/CFS.
    Disabil Stud Q. 2009;29:4-11].

Purpose
The current study compared these domains that were developed through consensus methods to one obtained through more empirical approaches using factor analysis.

Methods: using data mining, we compared and contrasted fundamental features of consensus-based criteria versus empirical latent factors. In general, these approaches found the domain of fatigue/post-exertional malaise as best differentiating patients from controls.

Results
Findings indicated that the Fukuda et al. criteria had the worst sensitivity and specificity.

Conclusions
These outcomes might help both theorists and researchers better determine which fundamental domains to be used for the case definition.

Comparing and contrasting consensus versus empirical domains, by Leonard A. Jason, Bobby Kot, Madison Sunnquist, Abigail Brown, Jordan Reed, Jacob Furst, Julia L. Newton, Elin Bolle Strand & Suzanne D. Vernon in Fatigue: Biomedicine, Health & Behavior [Published online: 26 Mar 2015]
URL:

Posted in News | Tagged , , , , | Comments Off on Comparison of consensus & empirical ME/CFS definitions & criteria

Countess of Mar on politics and ME

The Countess of Mar addressed the Royal Society of Medicine’s meeting: ME/CFS: Frontiers in research, clinical practice and public perception, Wednesday 18 March 2015

Ladies and gentlemen, I am grateful to the Royal Society of Medicine who have given me the opportunity to offer a political view of ME/CFS.

I will have been an Independent Crossbench member of the House of Lords for forty years in the autumn. For more than 20 of those years, with the help of a great many other people in the community, I have been trying to persuade governments of different colours that ME/CFS, together with organophosphate sheep dip poisoning, Gulf War Illnesses, Aerotoxic syndrome and other medically unexplained physical symptoms, known as MUPS, are not figments of patients’ imaginations, nor are they nocebo effects, but are very real conditions.

In so far as ME/CFS is concerned I have had some support from Members of Parliament who have constituents with the illness, but have been ploughing rather a long and lonely furrow in the Lords. For the sake of brevity, I will call the condition ME, which is what most patients prefer, except where accuracy demands otherwise. I know that the medical profession uses the shortcut term CFS, but that covers a much wider range of conditions that what I know of as classic ME.

I came to ME through parents who had used OP head louse shampoos on their children – treatments recommended by doctors and school nurses. Some children developed symptoms which were labelled ME within months of the treatment. I don’t know whether you recall that the advice was to shampoo the child’s head and, without rinsing, cover the head with a shower cap and leave overnight, to be rinsed off in the morning. Anyone with any knowledge of OPs knows that one of the most absorbent parts of the body is the scalp, and that some individuals are more genetically susceptible than others; so these poor children were poisoned.

Very unfortunately, once a person, be they child or adult, has the ME label all support and assistance from the medical profession and social services seem to vanish into thin air. Despite the World Health Organisation classification of CFS/ME as a neurological condition under ICD 10 G93.3 and this classification being accepted by Ministers of both the Department of Health and the Department for Work and Pensions; despite major reports, one by the Chief Medical Officers working group on CFS/ME in 2002 and two others by the All Party Parliamentary Group on ME in 2006 and 2010, all of which recognise the severe impact that this disease can have on many patients’ lives, far too many of those professionals treating and caring for people with ME have not received the message. The CMO Report mentions that “The disbelief and controversy over CFS/ME that exists within the professions has done nothing to dispel public disbelief in the existence of such a seemingly varied and inconsistent illness.” Despite all the fine words of Ministers and report writers, I repeatedly ask myself why it is that the recognition and treatment of this illness has remained in the doldrums for so long.

All Party Parliamentary Groups are supposed to be for the enlightenment of Members of Parliament from both Houses. The purpose of the APPG for ME is to: “Raise awareness of ME and support the improvement of health, social care, education and employment opportunities for people affected by ME.” There was a problem with communicating with Ministers effectively at what turned out to be large public meetings with few MPs present. After consultation with the leaders of the main ME charities and support groups, Forward-ME was formed in 2008 under my chairmanship. We have met successfully with people such as Steven Holgate, Lord Freud, Edward Timpson MP and ATOS as well as others in the health, social care and education world and are, I believe, respected for the respect that we show to each other and to our speakers. The APPG was re-formed in 2010 on these same principles and we now work together very happily, though meetings are still attended by very few MPs.

When we think of politics we tend to think of party politics – what goes on in the Westminster village, in local government or at the parish pump. It was a while before I recognised that amongst other settings there are medical politics. Until the 1980s, when the Press picked up on the ‘Yuppie flu’ diagnosis, there seems to have been tacit acceptance that ME was a real physical condition even though the cause was then, as it is now, unknown. There were a number on notable British doctors, amongst them Dr A Melvin Ramsay, who flew the flag for Myalgic Encephalomyelitis from the 1950s onwards, Dr Elizabeth Dowsett, Dr Alan Franklin and Dr John Richardson who, from their observations of ME patients over decades, were convinced that ME was caused by persistent viral infections.

This persistence would appear to be confirmed by Dr Mady Hornig and Dr Ian Lipkin at the Centre for Infection and Immunity at Columbia University’s Mailman School of Public Health in their 27 February 2015paper – ‘Immune Signatures in Blood Point to Distinct Disease Stages, Open Door to Better Diagnosis and Treatment’, who have identified distinct immune changes in patients, said to represent the first robust physical evidence the ME/CFS is a biological illness as opposed to a psychological disorder., though I readily acknowledge that we still have a long way to go.

It was when a small group psychiatrists from the UK, Europe and the USA purloined ME and renamed it CFS in the mid-1980s that the real problems began. They insisted that it was a psychosocial behavioural problem that could be readily overcome with a course of cognitive behavioural therapy and graded exercise. From their earliest beginnings, they managed to attract the attention of the media and of their medical colleagues with their assertions.

They found their way onto government advisory committees and research organisations; onto the boards of medical publications and into insurance companies where their message was greeted with apparent delight because these organisations would not have to think any more. The cause and solution were at hand. No need for doctors to do too many investigations; no need to perform anything but psychological research; no need for social security payments by finding that claimants are really fit for work. They developed a means of stifling opposition by refusing to publish papers showing biological causation and, joy of joys for the insurance companies found that patients were reporting a psychological condition which was excluded in their policies. As recently as last year CFS was described as ‘a culturally driven disorder with no known organic cause’ in the BMJ.

This school of psychiatrists has persisted in their view despite more than 6,000 peer reviewed papers, including experimental studies which demonstrate a range of biological findings associated with people with ME. Funding for biological causes and treatments is miniscule against the funding for psychiatric or psychological ones. Researchers such as those funded by Invest in ME and ME Research UK, have funded excellent pilot and seedcorn studies on a shoestring, while a significant number of biomedical research applications have not been funded by the MRC in the past 20 years, including some targeted at pathophysiology.

It is hard to believe that all were written so badly that they could be rejected, particularly as some came from established researchers with a track record in this and other fields. Could it be that the expert reviewers were, once again, psychiatrists who appeared to have an interest in supressing research that counters their views? Many suspect this to be the case. This can only be political. It is also political suicide for researchers in major universities to suggest that they conduct studies into biological causes for ME.

The largest and most expensive state-sponsored treatment studies (the PACE and FINE trials) which both focused exclusively on psychosocial management cost in excess of £6 million, dwarfing funding for biomedical intervention, yet both failed to show improvement on real-world outcome measures. These huge sums have taken us no nearer to finding a cure or the underlying cause.

There is a silver lining – more recently MRC funding has been targeted on more biological research, though the amounts of funding allocated are still miniscule in relation to that for other diseases.

It is extraordinary to me that men and women who are trained to “First do no harm” and to “Listen to the patient for they will probably tell you the diagnosis” cannot but be aware of the enormous damage they are doing to a very large number – more than 200.000, patients with this condition. By recommending that too many investigations should not be conducted because they encourage illness behaviour they are risking missing vital findings of treatable conditions such as endocrine dysfunction, rarer medical conditions or even cancers that present with chronic fatigue. How, with all the publicity, can they not be aware of the misery, neglect and, too often, abusive treatment that I can only describe as barbaric that is meted out to patients with a diagnosis of ME?

I am aware that multiple sclerosis, Parkinson’s disease and diabetes were all once in the domain of the psychiatrists and that this domain is shrinking as new discoveries are made. To compensate, we have a compendium of purely subjective conditions with labels such as conversion syndrome, pervasive refusal syndrome, and neurasthenia to name but a few. There is no biological explanation for these, but they do help the uninitiated to believe that the condition is psychological.

How can we change this situation? Frantz Fanon, the French psychiatrist, philosopher and revolutionary from the middle of the last century wrote:
“Sometimes people hold a core belief that is very strong. When they are presented with evidence that works against that belief, the new evidence cannot be accepted.

It would create a feeling that is extremely uncomfortable, called cognitive dissonance.  And because it is so important to protect that core belief, they will rationalise, ignore and even deny anything that doesn’t fit that core belief.”

Ladies and gentlemen, I know how very difficult it is to say “Sorry, I got it wrong”, especially when your whole career has been based on a particular belief. I have been told that, in medicine, nothing will change until the old guard moves on. The history of medicine is littered with instances of this phenomenon. It is my very sincere wish that the situation will change radically long before the changing of the guard.

Event agenda

 

 

Posted in News | Tagged , , | Comments Off on Countess of Mar on politics and ME

Claire Jones, Welsh harpist with ME

Claire Jones, former Royal harpist from Pembrokeshire, talks about her experience of ME and road to recovery through homeopathy, chiropractic treatment, nutrition and psychological therapies.

She advises people with ME to listen to their bodies and calls for better services. Her 4th solo album Journey reflects her journey through ME.

BBC Radi0 Wales: Eleri Sion 2nd March 2015 [interview begins 1h 36 – online until end of March]

Daily Mail article: I feared for career says Royal harpist Claire Jones hit by ME [scroll down]

Wales online: Former royal harpist Claire Jones on her ME fight

Times: ‘It’s a real illness and a physical one’: Claire Jones’s struggle with ME

Videos on You Tube

Claire Jones website

Posted in News | Tagged , | Comments Off on Claire Jones, Welsh harpist with ME

Distinct stages found in ME/CFS

Research abstract

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is an unexplained incapacitating illness that may affect up to 4 million people in the United States alone.

There are no validated laboratory tests for diagnosis or management despite global efforts to find biomarkers of disease. We considered the possibility that inability to identify such biomarkers reflected variations in diagnostic criteria and laboratory methods as well as the timing of sample collection during the course of the illness.

Accordingly, we leveraged two large, multicenter cohort studies of ME/CFS to assess the relationship of immune signatures with diagnosis, illness duration, and other clinical variables. Controls were frequency-matched on key variables known to affect immune status, including season of sampling and geographic site, in addition to age and sex.

We report here distinct alterations in plasma immune signatures early in the course of ME/CFS (n = 52) relative to healthy controls (n = 348) that are not present in subjects with longer duration of illness (n = 246).

Analyses based on disease duration revealed that early ME/CFS cases had a prominent activation of both pro- and anti-inflammatory cytokines as well as dissociation of intercytokine regulatory networks.

We found a stronger correlation of cytokine alterations with illness duration than with measures of illness severity, suggesting that the immunopathology of ME/CFS is not static. These findings have critical implications for discovery of interventional strategies and early diagnosis of ME/CFS.

Distinct plasma immune signatures in ME/CFS are present early in the course of illness, by Mady Hornig, José G. Montoya, Nancy G. Klimas, Susan Levine, Donna Felsenstein, Lucinda Bateman, Daniel L. Peterson, C. Gunnar Gottschalk, Andrew F. Schultz, Xiaoyu Che, Meredith L. Eddy, Anthony L. Komaroff, W. Ian Lipkin in Science Advances 27 Feb 2015: Vol. 1 no. 1  e1400121

Scientists discover robust evidence that Chronic Fatigue Syndrome is a biological illness (Columbia University)

BBC report: Distinct stages to chronic fatigue syndrome identified

The clock was (is) ticking: major study suggests ME/CFS is hit and run disorder, by Cort Johnson (Health Rising)

You tube video: Mady Hornig, MD, Associate Professor of Epidemiology and Director of Translational Research at the Center for Infection and Immunity discusses the impact that the latest findings may have on ME/CFS diagnosis and treatment

 

 

 

 

Posted in News | Tagged , , , , | Comments Off on Distinct stages found in ME/CFS

MRI shows differences between CFS and depression

Research article:

White matter (WM) involvement in chronic fatigue syndrome (CFS) was assessed using voxel-based regressions of brain MRI against CFS severity scores and CFS duration in 25 subjects with CFS and 25 normal controls (NCs).

As well as voxel-based morphometry, a novel voxel-based quantitative analysis of T1- and T2-weighted spin-echo (T1w and T2w) MRI signal level was performed.

Severity scores included the Bell CFS disability scale and scores based on the 10 most common CFS symptoms.

Hospital Anxiety and Depression Scale (HADS) depression and anxiety scores were included as nuisance covariates.

By relaxing the threshold for cluster formation, we showed that the T1w signal is elevated with increasing CFS severity in the ventrolateral thalamus, internal capsule and prefrontal WM.

Earlier reports of WM volume losses and neuroinflammation in the midbrain, together with the upregulated prefrontal myelination suggested here, are consistent with the midbrain changes being associated with impaired nerve conduction which stimulates a plastic response on the cortical side of the thalamic relay in the same circuits.

The T2w signal versus CFS duration and comparison of T2w signal in the CFS group with the NC group revealed changes in the right middle temporal lobe WM, where impaired communication can affect cognitive function.

Adjustment for depression markedly strengthened cluster statistics and increased cluster size in both T1w severity regressions, but adjustment for anxiety less so.

Thus, depression and anxiety are statistical confounders here, meaning that they contribute variance to the T1w signal in prefrontal WM but this does not correlate  with the co-located variance from CFS severity.

MRI regressions with depression itself only detected associations with WM volume, also located in prefrontal WM.

We propose that impaired reciprocal brain–body and brain–brain communication through the midbrain provokes peripheral and central responses which contribute to CFS symptoms.

Although anxiety, depression and CFS may share biological features, the present evidence indicates that CFS is a distinct disorder.

Evidence in chronic fatigue syndrome for severity-dependent upregulation of prefrontal myelination that is independent of anxiety and depression, by Leighton R. Barnden, Benjamin Crouch, Richard Kwiatek, Richard Burnet and Peter Del Fante in NMR in Biomedicine Vol 28 Issue 3, pages 404–413, March 2015 [Article first published online: 22 FEB 2015]

 

Posted in News | Tagged , , , | Comments Off on MRI shows differences between CFS and depression

Patients with a chronic condition need support to self-manage

Research review:

Background: Receiving adequate support seems to be crucial to the success of self-management. Although different empirical studies separately examined patients’ preferences for self-management support (SMS), an overview is lacking.

Objective: The aim of this qualitative review was to identify patients’ needs with respect to SMS and to explore by whom this support is preferably provided.

Search strategy: Qualitative studies were identified from Embase, MEDLINE OvidSP, Web of science, PubMed publisher, Cochrane central, the Cumulative Index to Nursing and Allied Health Literature (CINAHL) and PsycINFO.

Inclusion criteria: Articles needed to meet all of the following criteria: (i) focuses on self-management, (ii) concerns adult patients with rheumatic diseases (rheumatoid arthritis and fibromyalgia), a variant of cancer or chronic kidney disease, (iii) explores support needs from the patients’ perspective, (iv) uses qualitative methods and (v) published in English.

Data extraction and synthesis: A thematic synthesis, developed by Thomas and Harden, was conducted of the 37 included studies.

Main results: Chronic patients need instrumental support, psychosocial support and relational support from health-care professionals, family/friends and fellow patients to manage the chronic condition. Relational support is at the centre of the support needs and fuels all other types of support.

Discussion and conclusions: Patients do not self-manage on their own. Patients expect health-care professionals to fulfil a comprehensive role. Support needs can be knitted together only when patients and professionals work together on the basis of collaborative partnership. Dynamics in support needs make it important to regularly assess patient needs.

Self-management support from the perspective of patients with a chronic condition: a thematic synthesis of qualitative studies, by J Dwarswaard, EJ Bakker, A van Staa, HR Boeij, in Health Expect. 2015 Jan 26. [Epub ahead of print]

Posted in News | Tagged | Comments Off on Patients with a chronic condition need support to self-manage